Wiseguyreports.Com Adds “HERG Screening -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database
hERG Screening Market research report presents an in depth analysis of hERG Screening market. The study emphasizes on both technology and product segments of hERG Screening in biotechnology and pharmaceutical application areas. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more than 190 companies that are engaged in hERG Screening services and/or production of hERG screening tools/instruments. A global perspective is presented along with regional analysis covering North America, Europe, Asia-Pacific and Rest of World. Compilation of Worldwide Patents and Research related to hERG Screening is also provided. The hERG Screening market size is analyzed in US Dollars and includes 30 exclusive graphically illustrated exhibits.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/30790-herg-screening-market-research-report
Human Ether-a-go-go Related Gene (hERG gene) (KCNH2) is an encoder of the potassium ion channel that repolarizes IKr current in the heart. It consists of 6 transmembrane domains which are serially numbered from S1-S6. The abnormalities resulting in this channel can either lead to Long QT syndrome (LQT2) or Short QTsyndrome causing loss of function mutations and gain of function mutations respectively. Both of these are considered as potentially fatal cardiac arrhythmia caused due to repolarisation disturbances of the cardiac action potential. Global hERG screening market is projected to grow at 21.82%, compounded annually from 2005 through 2020. hERG Screening has its major role in the pharmaceutical field in drug release process. Some drugs may prolong the QT interval in normal and healthy individuals and result in QT Syndrome. This side effect has promoted majority of pharmaceutical companies to screen compounds for hERG channel activity in early stages of drug discovery and development process. Many companies are developing cell lines such as HEK 293, and CHO to aid in vitro screening for hERG channel activity.
Report by Chapter
I. Scope and Methodology: This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
II. Report Synopsis: Synopsis of the report summarizes the global hERG screening market. The chapter provides market values in US$ for hERG Screening in several geographic regions including the North America, Europe, Asia-Pacific and Rest of World.
III. Market Dynamics: Market Dynamics chapter provides information on global markets for hERG Screening. The chapter includes global market analysis (in US$) by geographic region; analysis of each region; a brief business profile of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches etc. The section includes key market trends and an industry outlook.
IV. Product/Technology Research: This chapter gives an insight into hERG screening market including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Importance of hERG screening in the drug discovery process, technology analysis and technology trends is discussed. Various research activities in the field of hERG Screening finds a mention in this chapter.
V. Corporate Directory: This chapter provides a global region-wise list of 190 plus companies, CROs and academic institutions that are engaged in hERG Screening products and/or services.
VI. Patents Information: This chapter provides a compilation of worldwide patents related to hERG screening products/services/technologies.
Why Buy This Report?
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Analytics and data presented in each report pertain to several parameters such as –
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: New York City
Country: United States